A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
Clinical trial NCT02057133 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02057133
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-10
- Primary completion
- 2021-03-15
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.